Stromal response to prostate cancer: nanotechnology-based detection of thioredoxin-interacting protein partners distinguishes prostate cancer associated stroma from that of benign prostatic hyperplasia.

Singer, Elizabeth

Stromal response to prostate cancer: nanotechnology-based detection of thioredoxin-interacting protein partners distinguishes prostate cancer associated stroma from that of benign prostatic hyperplasia. [electronic resource] - PloS one 2013 - e60562 p. digital

Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

1932-6203

10.1371/journal.pone.0060562 doi


Aged
Biomarkers, Tumor--genetics
CD4-Positive T-Lymphocytes--metabolism
Cryopreservation
Humans
Immunohistochemistry
Macrophages--metabolism
Male
Middle Aged
Nanotechnology--methods
Neutrophils--metabolism
Peroxiredoxins--genetics
Prostate--metabolism
Prostatectomy
Prostatic Hyperplasia--diagnosis
Prostatic Neoplasms--diagnosis
Protein Binding
Staining and Labeling
Stromal Cells--metabolism
Thioredoxin Reductase 1--genetics
Thioredoxin Reductase 2--genetics